RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,362,144 | +52.1% | 2,371,304 | +9.4% | 3.61% | +69.2% |
| Q2 2023 | $35,737,491 | -7.5% | 2,167,222 | +0.1% | 2.13% | -23.7% |
| Q1 2023 | $38,618,944 | -30.0% | 2,164,739 | +14.3% | 2.80% | -18.5% |
| Q4 2022 | $55,153,280 | +18.9% | 1,894,000 | 0.0% | 3.43% | -4.0% |
| Q3 2022 | $46,403,000 | – | 1,894,000 | – | 3.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |